IFNAR1 and systemic lupus erythematosus: Anifrolumab, a monoclonal antibody of IFNα receptor 1 (IFNAR1), is used to treat inflammatory autoimmune disease systemic lupus erythematosus (SLE), in which the immune system attacks its own tissues by blocking the pro-inflammatory type I IFNs pathway.